Nevertheless, while further interrogation of this therapeutic approach is necessary, our findings indicate LRP1 sheddases can be targeted to facilitate Aβ elimination from the brain, providing a novel therapeutic strategy to mitigate Aβ accumulation in the AD brain. The gene discussed is LRP1; the disease is Alzheimer disease.